To include your compound in the COVID-19 Resource Center, submit it here.

NICE still mulling changes

The U.K.'s NICE said it is undecided on how to amend its medicine and technology appraisal

Read the full 166 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE